Search

everythinglearnresearchcommunity

for

Search:↓

The PCL/PHB blend allows for slower, more controlled curcumin release than individual polymers.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Tribulus terrestris may protect the liver from drug damage.

Finasteride, a drug, can block the seizure-preventing effects of a hormone called progesterone in mice.

The protein p53 directly reduces the production of Keratin 17, a skin and hair protein, in rats with radiation dermatitis.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

The FDA approved a new Pfizer drug for hair loss in teens.

Finasteride may reduce prostate cancer risk.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

A specific gene mutation causes severe skin and nail issues and hair loss.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.